These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 9636512

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Clinical influencing factors for daily dose, trough level, and relative clearance of tacrolimus in renal transplant recipients.
    Hu RH, Lee PH, Tsai MK.
    Transplant Proc; 2000 Nov; 32(7):1689-92. PubMed ID: 11119894
    [No Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of tacrolimus in paediatric renal transplant recipients.
    Webb NJ, Stevenson PJ, Lewis MA, Postlethwaite RJ, Bradbury MG, Undre N.
    Transplant Proc; 2002 Aug; 34(5):1948-50. PubMed ID: 12176639
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Tacrolimus dosing requirements in diabetic and nondiabetic patients calculated from pretransplantation data.
    van Duijnhoven E, Christiaans M, Schäfer A, Undre N, van Hooff J.
    Transplant Proc; 1998 Jun; 30(4):1266-7. PubMed ID: 9636514
    [No Abstract] [Full Text] [Related]

  • 7. Long-term outcome of tacrolimus rescue therapy in late rejection after renal transplantation.
    Budde K, Smettan S, Fritsche L, Waiser J, Giessing M, Kunz R, Türk I, Bauer S, Mai I, Neumayer HH.
    Transplant Proc; 1998 Aug; 30(5):1780-1. PubMed ID: 9723280
    [No Abstract] [Full Text] [Related]

  • 8. Demographic considerations in tacrolimus pharmacokinetics.
    Fitzsimmons WE, Bekersky I, Dressler D, Raye K, Hodosh E, Mekki Q.
    Transplant Proc; 1998 Jun; 30(4):1359-64. PubMed ID: 9636552
    [No Abstract] [Full Text] [Related]

  • 9. Usefulness of monitoring of AUC(0-4h) during the induction period of immunosuppressive therapy with tacrolimus after renal transplantation.
    Uchida K, Tominaga Y, Haba T, Katayama T, Matsuoka S, Sato T, Goto N, Takeda A, Morozumi K, Takagi H.
    Transplant Proc; 2002 Aug; 34(5):1736-7. PubMed ID: 12176556
    [No Abstract] [Full Text] [Related]

  • 10. Specificity of therapeutic drug monitoring of tacrolimus in kidney transplant patients.
    Sato S, Fuchinoue S, Tojimbara T, Fujita S, Nakajima I, Agishi T, Hayashi T, Teramura Y, Fujita E, Iwasaki K.
    Transplant Proc; 1998 Jun; 30(4):1274-5. PubMed ID: 9636517
    [No Abstract] [Full Text] [Related]

  • 11. Study of pharmacokinetic parameters of tacrolimus by different oral administration periods in renal transplantation.
    Saito K, Suwa M, Nakagawa Y, Utsugi R, Tanikawa T, Tomita Y, Takahashi K.
    Transplant Proc; 2002 Aug; 34(5):1726-9. PubMed ID: 12176553
    [No Abstract] [Full Text] [Related]

  • 12. Defining the initial doses of sirolimus and tacrolimus in the period immediately after renal transplantation.
    Jiménez O, Campistol JM, Vidal E, Faura A, Oppenheimer F, Corbella J, Brunet M.
    Transplant Proc; 2003 Aug; 35(5):1686-8. PubMed ID: 12962758
    [No Abstract] [Full Text] [Related]

  • 13. Tacrolimus-based immunosuppression in renal transplantation: 78 experiences in a single Japanese center.
    Okamoto M, Omori Y, Kadotani Y, Ushigome H, Nakamura K, Akioka K, Yoshimura N.
    Transplant Proc; 2002 Aug; 34(5):1666. PubMed ID: 12176527
    [No Abstract] [Full Text] [Related]

  • 14. Therapeutic drug monitoring of tacrolimus in kidney transplantation: 9-month follow-up.
    Brunet M, Torregrosa JV, Oppenheimer F, Corbella J.
    Transplant Proc; 1998 Dec; 30(8):4068-9. PubMed ID: 9865298
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Evidence that fasting does not significantly affect trough levels of tacrolimus in stable renal transplant recipients.
    van Duijnhoven EM, Christiaans MH, Boots JM, van Hooff JP.
    Transplant Proc; 2002 Aug; 34(5):1723-5. PubMed ID: 12176552
    [No Abstract] [Full Text] [Related]

  • 19. Time-related clinical determinants of long-term tacrolimus pharmacokinetics in combination therapy with mycophenolic acid and corticosteroids: a prospective study in one hundred de novo renal transplant recipients.
    Kuypers DR, Claes K, Evenepoel P, Maes B, Coosemans W, Pirenne J, Vanrenterghem Y.
    Clin Pharmacokinet; 2004 Aug; 43(11):741-62. PubMed ID: 15301578
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of the new EMIT enzyme immunoassay for the determination of whole-blood tacrolimus concentrations in kidney, heart, and liver transplant recipients.
    Hesse CJ, Baan CC, Balk AH, Metselaar HJ, Weimar W, van Gelder T.
    Transplant Proc; 2002 Nov; 34(7):2988-90. PubMed ID: 12431679
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.